Expression of UBA52 in glioma - The Human Protein Atlas

GLIOBLASTOMA MULTIFORME (TCGA) - Interactive survival scatter plotⁱ

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisⁱ

UBA52 is not prognostic in Glioblastoma Multiforme (TCGA)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 1896.4

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average pTPM

1617.2

Number of samples

141

Samples

Sample	Description	pTPM
TCGA-27-2524-01A	56 years, male, white, stage:'--, dead, 231 days	2950.9
TCGA-12-3652-01A	60 years, male, white, stage:'--, dead, 1062 days	2904.9
TCGA-41-5651-01A	59 years, female, black or african american, stage:'--, dead, 460 days	2853.3
TCGA-19-2629-01A	60 years, male, white, stage:'--, dead, 737 days	2561.9
TCGA-14-0817-01A	69 years, female, white, stage:'--, dead, 164 days	2560.8
TCGA-26-5133-01A	59 years, male, white, stage:'--, alive, 452 days	2505.3
TCGA-12-3650-01A	46 years, male, white, stage:'--, dead, 333 days	2489.4
TCGA-14-2554-01A	52 years, female, white, stage:'--, dead, 532 days	2420.0
TCGA-28-5208-01A	52 years, male, white, stage:'--, dead, 544 days	2281.7
TCGA-12-5295-01A	60 years, female, white, stage:'--, dead, 454 days	2279.9
TCGA-02-2485-01A	53 years, male, black or african american, stage:'--, alive, 470 days	2242.3
TCGA-06-0211-01A	47 years, male, white, stage:'--, dead, 360 days	2192.9
TCGA-14-0871-01A	74 years, female, white, stage:'--, dead, 880 days	2175.6
TCGA-41-2572-01A	67 years, male, white, stage:'--, dead, 406 days	2171.7
TCGA-06-5416-01A	23 years, female, white, stage:'--, alive, 204 days	2138.6
TCGA-06-2563-01A	72 years, female, white, stage:'--, alive, 932 days	2122.3
TCGA-06-0190-01A	62 years, male, white, stage:'--, dead, 317 days	2091.2
TCGA-28-5218-01A	63 years, male, white, stage:'--, dead, 157 days	2090.2
TCGA-06-0174-01A	54 years, male, white, stage:'--, dead, 98 days	2071.0
TCGA-02-2483-01A	43 years, male, asian, stage:'--, alive, 466 days	2050.9
TCGA-06-0744-01A	66 years, male, white, stage:'--, dead, 1426 days	2026.7
TCGA-06-5414-01A	61 years, male, white, stage:'--, alive, 273 days	1991.3
TCGA-28-2513-01A	69 years, female, white, stage:'--, alive, 222 days	1983.8
TCGA-76-4927-01A	58 years, male, white, stage:'--, dead, 535 days	1977.1
TCGA-12-0616-01A	36 years, female, white, stage:'--, dead, 448 days	1959.9
TCGA-06-0178-01A	38 years, male, white, stage:'--, dead, 2681 days	1929.3
TCGA-27-2521-01A	34 years, male, white, stage:'--, dead, 510 days	1927.3
TCGA-06-0184-01A	63 years, male, white, stage:'--, dead, 2126 days	1898.8
TCGA-27-2528-01A	62 years, male, white, stage:'--, dead, 480 days	1896.4
TCGA-06-0645-01A	55 years, female, white, stage:'--, dead, 175 days	1885.1
TCGA-14-1034-01A	60 years, female, stage:'--, dead, 485 days	1877.7
TCGA-02-0055-01A	62 years, female, white, stage:'--, dead, 76 days	1865.4
TCGA-41-2571-01A	89 years, male, white, stage:'--, dead, 26 days	1864.3
TCGA-32-2638-01A	67 years, male, white, stage:'--, dead, 766 days	1861.5
TCGA-14-1823-01A	58 years, female, white, stage:'--, dead, 543 days	1851.7
TCGA-06-0686-01A	53 years, male, white, stage:'--, dead, 432 days	1844.0
TCGA-06-0745-01A	59 years, male, white, stage:'--, dead, 239 days	1840.5
TCGA-28-5209-01A	66 years, female, white, stage:'--, alive, 442 days	1836.3
TCGA-12-3653-01A	34 years, female, white, stage:'--, dead, 442 days	1830.4
TCGA-06-0747-01A	53 years, male, white, stage:'--, dead, 82 days	1818.6
TCGA-32-5222-01A	66 years, male, white, stage:'--, dead, 585 days	1804.7
TCGA-06-0125-01A	63 years, female, white, stage:'--, dead, 1448 days	1799.6
TCGA-12-5299-01A	56 years, female, white, stage:'--, dead, 98 days	1764.9
TCGA-06-2565-01A	59 years, male, asian, stage:'--, dead, 506 days	1762.8
TCGA-28-2509-01A	77 years, female, white, stage:'--, alive, 145 days	1758.4
TCGA-06-0743-01A	69 years, male, white, stage:'--, dead, 803 days	1754.2
TCGA-26-5139-01A	65 years, female, white, stage:'--, alive, 48 days	1753.4
TCGA-06-0158-01A	73 years, male, white, stage:'--, dead, 329 days	1752.6
TCGA-19-5960-01A	56 years, male, white, stage:'--, dead, 455 days	1730.9
TCGA-14-0789-01A	54 years, male, white, stage:'--, dead, 342 days	1707.0
TCGA-32-1982-01A	76 years, female, white, stage:'--, dead, 142 days	1698.1
TCGA-06-5412-01A	78 years, female, white, stage:'--, dead, 138 days	1692.4
TCGA-28-5216-01A	52 years, male, white, stage:'--, alive, 415 days	1692.0
TCGA-06-0157-01A	63 years, female, white, stage:'--, dead, 97 days	1686.8
TCGA-06-2569-01A	24 years, female, black or african american, stage:'--, alive, 13 days	1684.4
TCGA-32-1970-01A	59 years, male, white, stage:'--, dead, 468 days	1670.4
TCGA-06-0138-01A	43 years, male, white, stage:'--, dead, 737 days	1660.7
TCGA-06-0749-01A	50 years, male, black or african american, stage:'--, dead, 82 days	1657.7
TCGA-06-0130-01A	54 years, male, white, stage:'--, dead, 394 days	1652.9
TCGA-28-2514-01A	45 years, male, asian, stage:'--, alive, 160 days	1635.9
TCGA-02-2486-01A	64 years, male, white, stage:'--, dead, 618 days	1632.1
TCGA-19-1390-01A	63 years, female, white, stage:'--, dead, 772 days	1620.6
TCGA-32-2632-01A	80 years, male, white, stage:'--, dead, 269 days	1620.0
TCGA-41-3915-01A	48 years, male, white, stage:'--, dead, 360 days	1610.4
TCGA-06-0168-01A	59 years, female, white, stage:'--, dead, 598 days	1601.3
TCGA-06-5417-01A	45 years, female, white, stage:'--, alive, 155 days	1570.0
TCGA-06-0644-01A	71 years, male, black or african american, stage:'--, dead, 384 days	1564.8
TCGA-76-4931-01A	70 years, female, white, stage:'--, dead, 279 days	1562.4
TCGA-32-2616-01A	48 years, female, white, stage:'--, dead, 224 days	1556.5
TCGA-06-0139-01A	40 years, male, white, stage:'--, dead, 362 days	1556.4
TCGA-19-2620-01A	70 years, male, white, stage:'--, dead, 148 days	1544.7
TCGA-26-5135-01A	72 years, female, white, stage:'--, dead, 270 days	1542.1
TCGA-27-2523-01A	63 years, male, white, stage:'--, dead, 489 days	1538.7
TCGA-06-0750-01A	43 years, male, white, stage:'--, dead, 28 days	1537.5
TCGA-06-0210-01A	72 years, female, white, stage:'--, dead, 225 days	1512.8
TCGA-76-4932-01A	50 years, female, white, stage:'--, dead, 1458 days	1511.3
TCGA-76-4925-01A	76 years, male, white, stage:'--, dead, 146 days	1511.2
TCGA-12-0618-01A	49 years, male, white, stage:'--, dead, 395 days	1510.2
TCGA-06-5408-01A	54 years, female, white, stage:'--, dead, 357 days	1496.3
TCGA-15-0742-01A	65 years, male, white, stage:'--, dead, 419 days	1495.8
TCGA-19-4065-01A	36 years, male, white, stage:'--, alive, 214 days	1495.0
TCGA-06-2570-01A	21 years, female, white, stage:'--, alive, 958 days	1493.5
TCGA-06-5413-01A	67 years, male, white, stage:'--, alive, 268 days	1492.4
TCGA-32-4213-01A	47 years, female, white, stage:'--, alive, 604 days	1483.9
TCGA-16-0846-01A	85 years, male, white, stage:'--, dead, 119 days	1477.6
TCGA-14-1829-01A	57 years, male, black or african american, stage:'--, alive, 218 days	1476.4
TCGA-26-5132-01A	74 years, male, white, stage:'--, alive, 286 days	1472.1
TCGA-28-1753-01A	53 years, male, white, stage:'--, alive, 37 days	1460.9
TCGA-28-5204-01A	72 years, male, white, stage:'--, dead, 454 days	1459.6
TCGA-12-0821-01A	62 years, male, white, stage:'--, dead, 323 days	1444.7
TCGA-26-5134-01A	74 years, male, white, stage:'--, alive, 167 days	1443.3
TCGA-06-0129-01A	30 years, male, asian, stage:'--, dead, 1024 days	1441.2
TCGA-27-2526-01A	79 years, female, white, stage:'--, dead, 87 days	1433.5
TCGA-06-0132-01A	49 years, male, white, stage:'--, dead, 771 days	1430.2
TCGA-06-5410-01A	72 years, female, white, stage:'--, dead, 108 days	1422.3
TCGA-06-0156-01A	57 years, male, white, stage:'--, dead, 178 days	1420.5
TCGA-06-0238-01A	46 years, male, white, stage:'--, dead, 405 days	1418.4
TCGA-06-5856-01A	58 years, male, white, stage:'--, dead, 114 days	1415.3
TCGA-19-2625-01A	76 years, female, white, stage:'--, dead, 124 days	1411.2
TCGA-06-2557-01A	76 years, male, black or african american, stage:'--, dead, 33 days	1407.1
TCGA-28-5207-01A	71 years, male, white, stage:'--, dead, 343 days	1398.8
TCGA-28-5220-01A	67 years, male, white, stage:'--, dead, 388 days	1397.0
TCGA-08-0386-01A	74 years, male, white, stage:'--, dead, 548 days	1384.7
TCGA-32-2634-01A	82 years, male, white, stage:'--, alive, 693 days	1375.0
TCGA-27-1831-01A	66 years, male, white, stage:'--, dead, 505 days	1365.4
TCGA-06-5418-01A	75 years, female, white, stage:'--, dead, 83 days	1362.2
TCGA-32-2615-01A	62 years, male, white, stage:'--, dead, 485 days	1349.8
TCGA-14-1825-01A	70 years, male, white, stage:'--, dead, 232 days	1345.4
TCGA-06-5859-01A	63 years, male, white, stage:'--, alive, 139 days	1332.7
TCGA-06-2558-01A	75 years, female, white, stage:'--, dead, 380 days	1331.4
TCGA-06-0219-01A	67 years, male, white, stage:'--, dead, 22 days	1300.9
TCGA-06-2567-01A	65 years, male, white, stage:'--, dead, 133 days	1291.3
TCGA-32-1980-01A	72 years, male, white, stage:'--, dead, 36 days	1283.3
TCGA-41-4097-01A	63 years, female, white, stage:'--, dead, 6 days	1268.0
TCGA-27-1832-01A	59 years, female, white, stage:'--, dead, 300 days	1260.4
TCGA-27-1830-01A	57 years, male, white, stage:'--, dead, 154 days	1257.6
TCGA-06-0646-01A	60 years, male, white, stage:'--, dead, 175 days	1253.1
TCGA-19-2624-01A	51 years, male, white, stage:'--, dead, 5 days	1226.4
TCGA-06-0187-01A	69 years, male, white, stage:'--, dead, 828 days	1210.5
TCGA-26-1442-01A	43 years, male, white, stage:'--, alive, 953 days	1208.9
TCGA-28-5215-01A	62 years, female, white, stage:'--, dead, 335 days	1198.9
TCGA-12-0619-01A	60 years, male, white, stage:'--, dead, 1062 days	1195.1
TCGA-06-2562-01A	81 years, male, white, stage:'--, dead, 382 days	1189.5
TCGA-15-1444-01A	21 years, male, white, stage:'--, dead, 1537 days	1176.5
TCGA-06-5411-01A	51 years, male, white, stage:'--, dead, 254 days	1167.4
TCGA-06-0141-01A	62 years, male, white, stage:'--, dead, 313 days	1167.1
TCGA-27-1837-01A	36 years, male, white, stage:'--, dead, 427 days	1152.2
TCGA-06-2559-01A	83 years, male, white, stage:'--, dead, 150 days	1133.0
TCGA-06-5858-01A	45 years, female, white, stage:'--, alive, 187 days	1118.7
TCGA-27-1835-01A	53 years, female, white, stage:'--, dead, 648 days	1094.5
TCGA-19-2619-01A	55 years, female, black or african american, stage:'--, alive, 294 days	1090.5
TCGA-06-0878-01A	74 years, male, white, stage:'--, alive, 218 days	1065.4
TCGA-14-0787-01A	69 years, male, asian, stage:'--, dead, 68 days	1064.2
TCGA-27-1834-01A	56 years, male, white, stage:'--, dead, 1233 days	1054.1
TCGA-06-0882-01A	30 years, male, white, stage:'--, dead, 632 days	1053.3
TCGA-02-0047-01A	78 years, male, white, stage:'--, dead, 448 days	1005.7
TCGA-06-1804-01A	81 years, female, white, stage:'--, dead, 414 days	959.3
TCGA-06-2564-01A	50 years, male, white, stage:'--, alive, 181 days	953.8
TCGA-06-2561-01A	53 years, female, white, stage:'--, dead, 537 days	894.9
TCGA-27-2519-01A	48 years, male, white, stage:'--, dead, 550 days	869.3
TCGA-76-4929-01A	76 years, female, white, stage:'--, dead, 111 days	691.4
Show allShow less

GLIOBLASTOMA MULTIFORME (VALIDATION) - Interactive survival scatter plotⁱ

& Survival analysisⁱ

UBA52 is not prognostic in Glioblastoma Multiforme (validation)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 198.61

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average pTPM

250.5

Number of samples

Samples

Sample	Description	pTPM
AK133	N, NA, stage:NA, dead, 360 days	456.7
AK043	N, NA, stage:NA, alive, 660 days	388.4
AK066	N, NA, stage:NA, alive, 960 days	371.9
AK139	N, NA, stage:NA, dead, 270 days	368.3
AK074	N, NA, stage:NA, alive, 300 days	358.5
AK236	N, NA, stage:NA, dead, 360 days	338.2
AK002	N, NA, stage:NA, dead, 570 days	331.3
AK142	N, NA, stage:NA, alive, 90 days	320.6
AK123	N, NA, stage:NA, dead, 180 days	317.4
AK183	N, NA, stage:NA, alive, 360 days	313.5
AK195	N, NA, stage:NA, dead, 390 days	312.3
AK072	N, NA, stage:NA, dead, 150 days	311.4
AK178	N, NA, stage:NA, dead, 240 days	309.6
AK165	N, NA, stage:NA, alive, 360 days	296.5
AK134	N, NA, stage:NA, dead, 360 days	292.1
AK188	N, NA, stage:NA, alive, 420 days	290.4
AK153	N, NA, stage:NA, dead, 240 days	277.2
AK098	N, NA, stage:NA, dead, 660 days	274.4
AK158	N, NA, stage:NA, dead, 360 days	272.2
AK117	N, NA, stage:NA, dead, 210 days	266.6
AK185	N, NA, stage:NA, alive, 330 days	265.1
AK051	N, NA, stage:NA, dead, 360 days	264.8
AK088	N, NA, stage:NA, dead, 360 days	263.9
AK124	N, NA, stage:NA, alive, 1920 days	258.2
AK199	N, NA, stage:NA, alive, 1860 days	257.0
AK055	N, NA, stage:NA, dead, 240 days	256.6
AK216	N, NA, stage:NA, dead, 360 days	256.6
AK049	N, NA, stage:NA, dead, 180 days	254.7
AK226	N, NA, stage:NA, dead, 360 days	249.5
AK035	N, NA, stage:NA, dead, 210 days	246.1
AK085	N, NA, stage:NA, alive, 660 days	240.1
AK156	N, NA, stage:NA, dead, 330 days	232.4
AK041	N, NA, stage:NA, alive, 810 days	230.4
AK089	N, NA, stage:NA, dead, 330 days	230.2
AK231	N, NA, stage:NA, dead, 240 days	228.0
AK167	N, NA, stage:NA, dead, 180 days	226.3
AK100	N, NA, stage:NA, alive, 960 days	225.6
AK053	N, NA, stage:NA, dead, 300 days	221.0
AK030	N, NA, stage:NA, dead, 120 days	214.3
AK103	N, NA, stage:NA, alive, 1320 days	210.9
AK099	N, NA, stage:NA, dead, 420 days	210.8
AK149	N, NA, stage:NA, dead, 420 days	210.0
AK218	N, NA, stage:NA, dead, 180 days	206.2
AK205	N, NA, stage:NA, dead, 120 days	201.6
AK173	N, NA, stage:NA, dead, 180 days	200.9
AK213	N, NA, stage:NA, alive, 2010 days	196.3
AK076	N, NA, stage:NA, alive, 660 days	195.9
AK071	N, NA, stage:NA, dead, 540 days	188.7
AK079	N, NA, stage:NA, dead, 210 days	181.5
AK015	N, NA, stage:NA, alive, 720 days	179.8
AK091	N, NA, stage:NA, dead, 210 days	178.3
AK005	N, NA, stage:NA, dead, 240 days	176.3
AK068	N, NA, stage:NA, alive, 360 days	173.5
AK227	N, NA, stage:NA, alive, 300 days	162.3
AK003	N, NA, stage:NA, dead, 600 days	150.7
AK081	N, NA, stage:NA, dead, 180 days	149.6
AK102	N, NA, stage:NA, alive, 1740 days	140.4
AK006	N, NA, stage:NA, dead, 360 days	129.4
Show allShow less

GLIOBLASTOMA MULTIFORME - Protein relative expression (CPTAC)

Number of samples

110

Samples

Sample ID	Sample type	nRPX
CPT0186100003	Tumor	0.8
CPT0204330003	Normal	0.8
CPT0204420003	Normal	0.6
CPT0218770003	Tumor	0.6
CPT0104220003	Tumor	0.6
CPT0204390003	Normal	0.6
CPT0189650004	Tumor	0.6
CPT0087730003	Tumor	0.6
CPT0204410003	Normal	0.5
CPT0204350003	Normal	0.5
CPT0204360003	Normal	0.5
CPT0225760003	Tumor	0.5
CPT0217000004	Tumor	0.5
CPT0190240004	Tumor	0.4
CPT0217880003	Tumor	0.4
CPT0209440003	Tumor	0.4
CPT0189570004	Tumor	0.4
CPT0125570003	Tumor	0.4
CPT0217100003	Tumor	0.4
CPT0204370003	Normal	0.4
CPT0161730003	Tumor	0.4
CPT0224330003	Tumor	0.4
CPT0002410011	Tumor	0.3
CPT0204380003	Normal	0.3
CPT0204340003	Normal	0.3
CPT0064650003	Tumor	0.3
CPT0089150003	Tumor	0.3
CPT0167860004	Tumor	0.3
CPT0162020003	Tumor	0.3
CPT0225730003	Tumor	0.3
CPT0205890003	Tumor	0.3
CPT0189460003	Tumor	0.3
CPT0206780003	Tumor	0.3
CPT0196850003	Tumor	0.2
CPT0168720003	Tumor	0.2
CPT0221180003	Tumor	0.2
CPT0182550003	Tumor	0.2
CPT0217060003	Tumor	0.2
CPT0104330003	Tumor	0.2
CPT0071100003	Tumor	0.2
CPT0205780003	Tumor	0.2
CPT0206110003	Tumor	0.2
CPT0123530003	Tumor	0.2
CPT0207030003	Tumor	0.2
CPT0167970003	Tumor	0.2
CPT0201710003	Tumor	0.2
CPT0204400003	Normal	0.2
CPT0207090003	Tumor	0.2
CPT0206450003	Tumor	0.2
CPT0218890004	Tumor	0.2
CPT0189250003	Tumor	0.1
CPT0205670004	Tumor	0.1
CPT0167750004	Tumor	0.1
CPT0189750004	Tumor	0.1
CPT0087950003	Tumor	0.1
CPT0162140003	Tumor	0.1
CPT0167530003	Tumor	0.1
CPT0093550003	Tumor	0.1
CPT0206880003	Tumor	0.1
CPT0217710008	Tumor	0.1
CPT0206670004	Tumor	0.0
CPT0218690004	Tumor	0.0
CPT0206000004	Tumor	0.0
CPT0168590003	Tumor	0.0
CPT0189850004	Tumor	0.0
CPT0087680003	Tumor	0.0
CPT0217190003	Tumor	0.0
CPT0218330004	Tumor	0.0
CPT0218670003	Tumor	0.0
CPT0228220003	Tumor	0.0
CPT0168480003	Tumor	0.0
CPT0078580003	Tumor	0.0
CPT0125220003	Tumor	0.0
CPT0199770003	Tumor	0.0
CPT0206560003	Tumor	-0.1
CPT0127480003	Tumor	-0.1
CPT0168270003	Tumor	-0.1
CPT0168380003	Tumor	-0.1
CPT0125510003	Tumor	-0.1
CPT0224600003	Tumor	-0.1
CPT0208980003	Tumor	-0.1
CPT0206330003	Tumor	-0.1
CPT0093590003	Tumor	-0.1
CPT0093360003	Tumor	-0.1
CPT0216920008	Tumor	-0.2
CPT0182500003	Tumor	-0.2
CPT0162100003	Tumor	-0.2
CPT0182580003	Tumor	-0.2
CPT0218960004	Tumor	-0.2
CPT0168830003	Tumor	-0.2
CPT0190360004	Tumor	-0.2
CPT0219080004	Tumor	-0.2
CPT0205450004	Tumor	-0.2
CPT0168080003	Tumor	-0.2
CPT0224390004	Tumor	-0.2
CPT0064890003	Tumor	-0.2
CPT0175060003	Tumor	-0.3
CPT0093450003	Tumor	-0.3
CPT0224540004	Tumor	-0.3
CPT0205570003	Tumor	-0.3
CPT0167640003	Tumor	-0.3
CPT0087570003	Tumor	-0.4
CPT0092440003	Tumor	-0.4
CPT0171580008	Tumor	-0.4
CPT0079790003	Tumor	-0.4
CPT0127420003	Tumor	-0.5
CPT0093510003	Tumor	-0.5
CPT0217430008	Tumor	-0.5
CPT0206230003	Tumor	-0.5
CPT0218830004	Tumor	-0.8
Show allShow less

GLIOMA - Protein expressionⁱ A mouse-over function shows sample information and annotation data. Click on an image to view it in a full screen mode. Samples can be filtered based on level of antibody staining by selecting one or several of the following categories: high, medium, low and not detected. The assay and annotation is described here. Note that samples used for immunohistochemistry by the Human Protein Atlas do not correspond to samples in the TCGA dataset.

Antibody stainingⁱ Antibody staining in the annotated cell types in the current human tissue is reported as not detected, low, medium, or high, based on conventional immunohistochemistry profiling in selected tissues. This score is based on the combination of the staining intensity and fraction of stained cells. Each image is clickable and will lead to virtual microscopy that enables deeper exploration of all samples and also displays staining intensity scores, fraction scores and subcellular localization as well as patient and tissue information for each sample.	Antibody HPA041344	Antibody HPA049132
Staining
High
Medium
Low
Not detected
Intensity
Strong
Moderate
Weak
Negative
Quantity
>75%
75%-25%
<25%
None
Location
Nuclear
Cytoplasmic/membranous
Cytoplasmic/membranous,nuclear
None
Glioma, malignant, Low grade
Glioma, malignant, High grade